1 / 8

Non Hodgkin Lymphoma Market Trends, Dynamics & Market Insights

The Non-Hodgkin Lymphoma (NHL) market is projected to grow from USD 8.1 billion in 2020 to USD 12.4 billion by 2026 at a CAGR of around 7.4% during the forecast period.<br><br>

SagarJoshi
Télécharger la présentation

Non Hodgkin Lymphoma Market Trends, Dynamics & Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Presents a Research Report on Non Hodgkin Lymphoma Market The report on the Non Hodgkin Lymphoma Market is segmented By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates, BTK/BCL-2 Kinase Inhibitors, PI3 Kinase Inhibitors, Protease Inhibitors, Others), Application (Hospital, Clinic), and Region - COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Non-Hodgkin Lymphoma (NHL) market. sales@stratviewresearch.com +1-313-307-4176 www.stratviewresearch.com Market Reports Advisory & Consulting Sourcing Intelligence

  2. The Non Hodgkin Lymphoma Market Highlights& Drivers • The Non-Hodgkin Lymphoma (NHL) market is projected to grow from USD 8.1 billion in 2020 to USD 12.4 billion by 2026 at a CAGR of around 7.4% during the forecast period. • The growth of the non-Hodgkin lymphoma (NHL) market is primarily driven by increasing incidences of lymphoma cancer disease across geographies. • Changing lifestyles and unhealthy diets are some of the factors resulting in cancer disease, which is likely to drive the market growth at a significant rate during the review period. • MarketInsight • By Type: • By type, the non-Hodgkin lymphoma (NHL) market has been bifurcated into hospitals and clinics. Under these, the hospital segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. • The segment growth can be attributed to the presence of established infrastructure and skilled healthcare staff.

  3. Market Insight & Competitive Insights • By Region: • By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. • The segment growth is primarily attributed to the rising number of people suffering from lymphoma cancer coupled with the presence of key market players such as Bristol Myers Squibb (US) and Celgene Corporation (US). • The market growth in the Asia-Pacific region is expected to be driven by the increasing prevalence of cancer disease. • Key Players • F. Hoffmann-La Roche AG (Switzerland) • Johnson & Johnson (US) • The Merck Group (Germany) • Bristol Myers Squibb (US) • Celgene Corporation (US) • Eli Lilly and Company (US) • GlaxoSmithKline plc (UK) • Bayer AG (Germany) • AstraZeneca plc (UK) • The Takeda Pharmaceutical Company Limited (Japan).

  4. Data Analysis (Top Down and Bottom Up Approach) Research Methodology Data Triangulation (Data Evaluation and Multiple Data Triangulation) Final Deliverables (Final Report with All Findings) Stratview Research follows a rigorous methodology with high emphasis on primary research and multiple ways of data triangulation. We conduct primary research across the value chain to provide 360 degree view of the market. • Secondary Research • Stratview Research Internal Knowledgebase Primary Research • Annual Reports / Fact Book • Company Websites • Magazines / Publications • Press Releases & Journals • Industry News • Association Articles • Government Documents • Social Media • Others • Robust database across value chain • In-house industry veterans as advisors • Project based subject matter experts • Industry Players • Industry Experts • Suppliers • Customers • Associations • Government Institutions • Others

  5. Report Features • This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report: • Market structure: Overview, industry life cycle analysis, supply chain analysis. • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis. • Market trend and forecast analysis. • Market segment trend and forecast. • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc. • Attractive market segments and associated growth opportunities. • Emerging trends. • Strategic growth opportunities for the existing and new players. • Key success factors.

  6. About Stratview Research Stratview Research is a global market intelligence firm providing high quality syndicated reports, custom research and consulting services. Our Services Why Us? High Customer Delight Rich Industry Experience Robust Methodology Effective Business Decisions

  7. Contact Us for More Information and Sample Pages Ask for Sample Pages here: https://www.stratviewresearch.com/Request-Sample/2277/Non-Hodgkin-Lymphoma-(NHL)-Market.html#form Email us at: sales@stratviewrsearch.com Call Us: +1-313-307-4176

  8. Thank you

More Related